Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial and intravenous use. It enhances radiographic visualization of vascular and tissue structures during imaging procedures and is employed to improve diagnostic accuracy in angiography, computed tomography, urography and cardiac catheterization. GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and imaging centres worldwide.

Iomeron (iomeprol) is an iodinated contrast agent used in radiographic imaging to improve visualization of vascular and organ structures. - Angiography: enhances delineation of blood vessels for diagnostic and interventional procedures. - Computed tomography (CT) imaging: increases attenuation differences, allowing clearer cross‑sectional images of organs and lesions. - Urography: improves contrast of urinary tract structures during excretory phase imaging. - Cardiac catheterization: provides detailed visualization of coronary arteries and cardiac chambers.

Iomeron may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Warm sensation or flushing at the injection site. - Metallic taste or altered taste perception. - Nausea or mild vomiting. - Headache. - Transient urticaria or mild skin itching.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions. - Contrast‑induced nephropathy leading to acute kidney injury. - Thyroid dysfunction due to iodine load. - Severe hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Persistent skin rash or severe urticaria.

Before using Iomeron, clinicians should consider several safety measures. - Assess renal function: evaluate serum creatinine and eGFR prior to administration. - Screen for iodine allergy: obtain detailed history of hypersensitivity to contrast media. - Ensure adequate hydration: encourage fluid intake or intravenous hydration to reduce nephrotoxic risk. - Monitor thyroid status: be cautious in patients with known thyroid disease. - Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iomeron can interact with certain medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis; discontinue before contrast if renal function is impaired. - Iodine‑containing drugs (e.g., amiodarone): may increase total iodine load. - Nephrotoxic agents (e.g., NSAIDs, aminoglycosides): heighten risk of contrast‑induced nephropathy.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may affect renal perfusion; monitor kidney function closely. - Diuretics: can influence fluid balance; observe hydration status during and after administration.